The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck
NCT05808920 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2026-02-12
Summary
The RESCUE study is a combined retrospective and prospective multicentre cohort study investigating the survival and functional outcomes in patients undergoing salvage surgery for recurrent, residual, and new primary head and neck squamous cell carcinoma (SCC).
Additionally, the RESCUE study will contain an exploratory molecular analysis of consenting patients to assess the relationship between cancer genomics, previous radiotherapy, and recurrence in head and neck cancer.
Conditions
Interventions
- GENETIC
-
Molecular Analyses
Nucleic acid extraction, protein analysis. Tumour tissue, blood and saliva samples collected.
Sponsors & Collaborators
-
Royal Marsden NHS Foundation Trust
lead OTHER
Principal Investigators
-
Vinidh Paleri · Royal Marsden Hospital NHS Foundation Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-08
- Primary Completion
- 2028-04-30
- Completion
- 2029-04-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
NCT06420219 ·Status: RECRUITING
-
Liquid Biopsy in Head and Neck Cancer
NCT03926468 ·Status: UNKNOWN
-
Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck
NCT00002695 ·Status: COMPLETED
-
One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma
NCT02852343 ·Status: COMPLETED
-
Contribution of Residual Tumour DNA Testing on the Surgical Bed
NCT05934929 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
IReC-Bio and IReC Registry
NCT05885490 ·Status: NOT_YET_RECRUITING
-
Head and Neck Cancer Screening and Serum Repository
NCT00592371 ·Status: COMPLETED
-
Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer
NCT05710679 ·Status: RECRUITING ·Phase: NA
-
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT04099290 ·Status: RECRUITING
-
Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00898911 ·Status: COMPLETED
-
CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.
NCT02789384 ·Status: RECRUITING ·Phase: NA
-
Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer
NCT05837260 ·Status: RECRUITING
-
Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
NCT06606028 ·Status: RECRUITING
-
Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip
NCT06678724 ·Status: RECRUITING
-
Study of Proteins in Head and Neck Cancer Cells
NCT00896948 ·Status: COMPLETED
-
CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases
NCT02058953 ·Status: COMPLETED
-
Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer
NCT00897052 ·Status: COMPLETED
-
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
NCT00230308 ·Status: RECRUITING
-
Analysis of Expression of Specific Markers in Hepatocellular Carcinoma
NCT00858000 ·Status: COMPLETED
-
Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity
NCT05791149 ·Status: RECRUITING ·Phase: NA
-
Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea
NCT02538562 ·Status: COMPLETED
-
Prognostic Markers for a Better Follow-up in Head and Neck Cancer.
NCT06094985 ·Status: RECRUITING
-
Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors
NCT00580463 ·Status: COMPLETED
-
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
NCT00568490 ·Status: RECRUITING
-
Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit
NCT05360225 ·Status: COMPLETED